Icon Q1 Adjusted Earnings, Revenue Fall

Published on 30/04/2025 at 22:51

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about ICON Public Limited Company

ICON Public Limited Company, Q1 2025 Earnings Call, May 01, 2025	07-14
Truist Trims Price Target on ICON to $187 From $190, Keeps Buy Rating	07-09	MT
Trump's Tariff Blitz Roils Markets, Targets EU and Apple	05-23
Analyst recommendations: Crowdstrike, AMD, Boeing, Intuit, Okta…	05-23
Truist Securities Adjusts Price Target on ICON to $190 From $208, Keeps Buy Rating	05-05	MT
Deutsche Bank Adjusts ICON Price Target to $200 From $235, Maintains Buy Rating	05-01	MT
ICON Seeks M&A Opportunities	05-01	CI
Icon Q1 Adjusted Earnings, Revenue Fall	04-30	MT
Icon Reports First Quarter 2025 Results	04-30	RE
Earnings Flash (ICLR) ICON PLC Reports Q1 Adjusted EPS $3.19, vs. FactSet Est of $3.10	04-30	MT
Earnings Flash (ICLR) ICON PLC Posts Q1 Revenue $2B, vs. FactSet Est of $2.01B	04-30	MT
Tranche Update on ICON Public Limited Company's Equity Buyback Plan announced on February 19, 2025.	04-30	CI
Tranche Update on ICON Public Limited Company's Equity Buyback Plan announced on October 25, 2024.	04-30	CI
Icon Public Limited Company Updates Earnings Guidance for Full Year 2025	04-30	CI
ICON Public Limited Company Reports Earnings Results for the First Quarter Ended March 31, 2025	04-30	CI
Analyst recommendations: Meta Platforms, Progressive, Equifax, SBA Communications, Cadence Design Systems...	04-29
JPMorgan Downgrades ICON to Neutral From Overweight, Adjusts Price Target to $150 From $265	04-29	MT
BofA Securities Cuts Price Target on ICON to $204 From $255	04-14	MT
Lost in tariffs	04-14
TD Cowen Downgrades ICON to Hold From Buy, Adjusts Price Target to $157 From $254	04-14	MT
Analyst recommendations: Apple, Blackstone, Estee Lauder, Mongodb, Stellantis…	04-14
Truist Adjusts ICON's Price Target to $208 From $262, Keeps Buy Rating	04-10	MT
Barclays Downgrades ICON to Equalweight From Overweight, Adjusts Price Target to $165 From $240	04-10	MT
Telix Pharmaceuticals Limited Announces Appointment of Anne Whitaker as A Non-Executive Director Based in the United States, Effective 7 April 2025	04-03	CI
ICON Public Limited Company's Equity Buyback announced on October 25, 2024, has closed with 1,360,537 shares, representing 1.68% for $250 million.	03-30	CI